Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
Three quarters of the drugs previously only accessible to patients via the Cancer Drugs Fund (CDF) are now approved on the NHS.
In part 3 of our World Cancer Day series, we take a look at how liver cancer affects different regions across the world.
A modified virus could be used to launch an immune attack on liver cancer cells, a new study has revealed.
Combining radioactive particles with chemotherapy slowed growth of liver tumours for almost eight months longer than chemotherapy alone.
A genetically-engineered virus has prolonged the lives of terminally ill liver cancer patients in a small clinical trial.